SETBP1 and myeloid neoplasm: In the past, scholars focused on the relationship between SETBP1 mutations and tumors, especially myeloid malignancies and SETBP1 mutations was served as a biomarker for the diagnosis and poor prognosis of myeloid malignancies and the overlap syndrome [27].